Development of a rubella virus DNA vaccine

Vaccine

Volumn 17, Issue 15-16, 1999, Pages 2104-2112

  Pougatcheva, Svetlana O ^a   Abernathy, Emily S ^a   Vzorov, A N ^b   Compans, Richard W ^b   Frey, Teryl K ^a  

^a GEORGIA STATE UNIVERSITY   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA VACCINE; RUBELLA VACCINE;

ANIMAL CELL; ARTICLE; DNA SEQUENCE; GENE GUN; NONHUMAN; PRIORITY JOURNAL; RUBELLA; RUBELLA VIRUS; VIRION;

AGGLUTINATION TESTS; ANIMALS; ANTIBODIES, VIRAL; BIOLISTICS; CELL LINE; DNA, COMPLEMENTARY; FEMALE; GENETIC VECTORS; IMMUNIZATION, SECONDARY; MICE; MICE, INBRED BALB C; NEUTRALIZATION TESTS; RNA, VIRAL; RUBELLA VACCINE; RUBELLA VIRUS; TRANSFECTION; VACCINES, DNA; VIRAL CORE PROTEINS; VIRAL ENVELOPE PROTEINS;

EID: 0033538040     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(98)00371-5     Document Type: Article

References (34)

1. Centers for Disease Control Rubella and congenital rubella syndrome, United States 1994-1997. Morbidity and Mortality Weekly Report. 46:1997;350-354.
2. Centers for Disease Control Recommended childhood immunization schedule, United States 1998. JAMA. 279:1998;495-496.
3. Centers for Disease Control Rubella Prevention: recommendations of the Immunization Practices Advisory Committee. Morbidity and Mortality Weekly Report. 39(RR-15):1990;1-18.
4. Plotkin SA. Rubella vaccine. In: Plotkin SA, Mortimer EA, editors. Vaccines, 2nd ed. Philadelphia: WB Saunders, 1994. p. 303-36.
5. Tingle A.J., Allen M., Petty R.E., Kettyls G.D., Chantler J.K. Rubella-associated arthritis. I. Comparative study of joint manifestation associated with natural rubella infection and RA 27/3 rubella immunization. Ann Rheum Dis. 45:1986;110-114.
6. Slater P.E., Ben-Zvi T., Fogel A., Ehrenfeld M., Ever-Hadani S. Absence of an association between rubella vaccination and arthritis in underimmune postpartum women. Vaccine. 13:1995;1529-1532.
7. Tingle A.J., Mitchell L.A., Grace M., Middleton P., Mathias R., MacWilliam L., Chalmers A. Randomised double-blind placebo-controlled study on adverse effects of rubella immunisation in seronegative women. Lancet. 349:1997;1277-1281.
8. Ray P., Black S., Shinefield H., Dillon A., Schwaibe J., Holmes S., Hadler S., Chen R., Cochi S., Wassilak S. Risk of chronic arthropathy among women after rubella vaccination. JAMA. 278:1997;551-556.
9. Weibel R.E., Benor D.E. Chronic arthropathy and musculoskeletal symptoms associated with rubella vaccines: a review of 124 claims submitted to the National Vaccine Injury Compensation Program. Arthritis Rheum. 39:1996;1529-1534.
10. Robertson S.E., Cutts F.T., Samuel R., Diaz-Ortega J.L. Control of rubella and congenital rubella syndrome (CRS) in developing countries. 2 Vaccination against rubella. Bull. World Health Org. 75:1997;69-80.
11. Frey T.K. Molecular biology of rubella virus. Adv Virus Res. 44:1994;69-160.
12. Terry G.M., Ho-Terry L., Londesborough P., Rees K.R. A bioengineered rubella E1 antigen. Arch Virol. 104:1989;63-75.
13. Qiu Z., Ou D., Wu H., Hobman T.C., Gillam S. Expression and characterization of virus-like particles containing rubella virus structural proteins. J Virol. 68:1994;4086-4091.
14. Grangeot-Keros L., Pustowoit B., Hobman T. Evaluation of Cobas core rubella IgG EIA recomb, a new enzyme immunoassay based on recombinant rubella-like particles. J Clin Microbiol. 33:1995;2392-2394.
15. Ulmer J.B., Sadoff J.C., Liu M.A. DNA vaccines. Curr Opin Immunol. 8:1996;531-536.
16. Pugachev K.V., Abernathy E.S., Frey T.K. Improvement of the specific infectivity of the rubella virus (RUB) infectious clone: determinants of cytopathogenicity induced by RUB map to the nonstructural proteins. J Virol. 1:1997;562-568.
17. Wilson K. Preparation of genomic DNA from bacteria. In: Ausubel FM, Brent R, et al., editors. Current protocols in molecular biology. New York: John Wiley and Sons, 1994. p. 2.4.1-5.
18. Kingston RE. Introduction of DNA into mammalian cells. In: Ausubel FM, Brent R, et al., editors. Current protocols in molecular biology. New York: John Wiley and Sons, 1994. p. 9.1.4-9.
19. Wolinsky J.S., McCarthy M., Allen-Cannady O., Moore W.T., Jin R., Cao S.N., Lovett A., Simmons E. Monoclonal antibody-defined epitope map of expressed rubella virus protein domains. J Virol. 65:1991;3986-3994.
20. Oxford J.S. The growth of rubella virus in small laboratory animals. J Immunol. 98:1967;697-701.
21. Sedegah M., Hedstrom R., Hobart P., Hoffman S.L. Protection against malaria by immunization with plasmid DNA encoding circumsporozoite protein. Proc Natl Acad Sci USA. 91:1994;9866.
22. Justewicz D.M., Webster R.G. Long-term maintenance of B cell immunity to influenza virus hemagglutinin in mice following DNA-based immunization. Virology. 224:1996;10-17.
23. Chow M.-H., Huang W.-L., Chi W.-K., Chu Y.-D., Tao M.-H. Improvement of hepatitis B virus DNA vaccines by plasmids coexpressing hepatitis B surface antigen and interleukin-2. J Virol. 70:1996;169-178.
24. Feltquate D.M., Heaney S., Webster R.G., Robinson H.L. Different T helper cell types and antibody isotypes generated by saline and gene gun DNA immunization. J Immunol. 158:1997;2278-2284.
25. Klinman D.M., Yamshchikov G., Ishigatsubo Y. Contribution of CpG motifs to the immunogenicity of DNA vaccines. J Immunol. 158:1997;3635-3639.
26. Carver D.H., Seto D.S.Y., Marcus P.I., Rodrigues L. Rubella virus replication in the brains of suckling mice. J Virol. 1:1967;1089-1090.
27. Weller T.H., Neva F.A. Propagation in tissue culture of cytopathic agents from patients with rubella-like illness. Proc Soc Exp Biol Med. 111:1962;215-225.
28. Parkman P.D., Buescher E.L., Artenstein M.S. Recovery of rubella virus from army recruits. Proc Soc Exp Biol Med. 111:1962;225-230.
29. Avila L., Rawls W.E., Dent P.B. Experimental infection with rubella virus. I. Acquired and congenital infection in rats. J Infect Dis. 126:1972;585-592.
30. Kono R., Hibi M., Hayakawa Y., Ishii K. Experimental vertical transmission of rubella virus in rabbits. Lancet. 1:1969;343-347.
31. London W.T., Fuccillo D.A., Sever J.L. Congenital rubella in rabbits. Symp Ser Immunobiol Standard. 11:1969;121-124.
32. Rubascan Product Insert. Becton Dickinson Cockeysville, MD: Microbiology Systems.
33. Skendzel L.P. Rubella immunity: defining the level of protective antibody. Am J Clin Pathol. 106:1996;170-174.
34. Plotkin S.A., Farquhar J.D., Ogra P.L. Immunologic properties of the RA27/3 rubella virus vaccine: a comparison with strains presently licensed in the United States. JAMA. 225:1973;585-590.